FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to a composition comprising, as an antifungal agent, at least 2·1010 CFU lactobacilli in the form of a single dose and a sulpho-containing compound for use as a first-line therapy for candidiasis infections and recurrent candidiasis infections.
EFFECT: disclosed are compositions for treating candidiasis infections.
13 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
| LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF | 2013 |
|
RU2661102C2 |
| PROBIOTIC STRAINS Lactobacillus AND THEIR CONSORTIUM FOR PROPHYLAXIS AND TREATMENT OF UROGENITAL INFECTIOUS DISEASES OF FEMALES | 2012 |
|
RU2504580C1 |
| Lactobacillus fermentum Ess-1, DSM17851, AND ITS APPLICATION FOR TREATMENT AND/OR PREVENTION OF CANDIDOSIS AND URINARY TRACT INFECTIONS | 2006 |
|
RU2413761C1 |
| Lactobacillus jensenii BACTERIA STRAIN HAVING WIDE SPECTRUM OF ANTAGONIST ACTIVITY AND PROBIOTIC CONSORTIUM OF LACTIC ACID BACILLUS TO PREPARE BACTERIAL FERTILISERS | 2015 |
|
RU2572351C1 |
| EFFERVESCENT COMPOSITION IN SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR TREATING VAGINAL INFECTIONS | 2012 |
|
RU2587717C2 |
| PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
| ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON BACTERIAL STRAIN | 2015 |
|
RU2616899C1 |
| COMPOSITION CONTAINING LACTIC ACID AND LACTOFERRIN | 2005 |
|
RU2398575C2 |
| METHOD FOR KILLING MICROORGANISMS IN BIOFILMS | 2022 |
|
RU2802523C1 |
